scholarly journals Omental Nodular Deposits of Recurrent Chromophobe Renal Cell Carcinoma Seen on FDG-PET/CT

2014 ◽  
Vol 4 ◽  
pp. 51 ◽  
Author(s):  
Aung Zaw Win ◽  
Carina Mari Aparici

We present the case of a 69-year-old male with chromophobe renal cell carcinoma (RCC). Chromophobe RCC accounts for only 4% of renal cancers and it is the least aggressive type. Omental nodular deposits due to RCC metastasis are very rare and it is reported only in more aggressive forms of RCC. This is the first report that shows FluoroDeoxyGlucose – Positron Emission Tomography/Computed Tomgraphy (FDG-PET/CT) images of omental nodular deposits from chromophobe RCC. FDG-PET/CT is becoming very useful in restaging RCC with distant metastases.

2021 ◽  
Vol 16 (4) ◽  
pp. 160-169
Author(s):  
V. S. Ilyakov ◽  
Artem Pronin ◽  
A. I. Mikhaylov ◽  
A. V. Parnas ◽  
Nadezhda Meshcheriakova ◽  
...  

Positron emission tomography combined with computed tomography (PET/CT) is a method, capable of evaluation of not only structural, but also metabolic alterations in organs and tissues. 18F-fluorodeoxyglucose (18F-PDG) PET/CT is widely used in diagnostics of various malignant tumors, but its role in renal cell carcinoma (RCC) remains obscure.Despite its limited effectiveness in primary and differential diagnosis of RCC, PET/CT can be used to determine the grade of malignancy and the histological type of tumor. According to various authors, 18F-FDG standardized uptake value (SUV) of a renal neoplasm can serve as an independent prognostic factor of overall survival.18F-FDG PET/CT is widely used to detect local recurrence and metastatic lesions in various neoplastic processes. Numerous studies confirm the high efficiency of PET/CT in detection of metastases and recurrence discernment for RCC.The ability to assess the metabolic activity of neoplastic foci using PET/CT may allow for evaluation of RCC therapy effectiveness, which is confirmed by clinical studies of various targeted therapy agents, such as tyrosine kinase inhibitors, mammalian target of rapamycin inhibitors, and monoclonal antibodies.Thus, there is growing evidence that 18F-FDG PET/CT is a useful tool in diagnostics of RCC.


2015 ◽  
Vol 43 (3) ◽  
pp. 464-473 ◽  
Author(s):  
Pierpaolo Alongi ◽  
Maria Picchio ◽  
Fabio Zattoni ◽  
Marianna Spallino ◽  
Luigi Gianolli ◽  
...  

2015 ◽  
Vol 26 (6) ◽  
pp. 1852-1862 ◽  
Author(s):  
Reiko Nakajima ◽  
Koichiro Abe ◽  
Tsunenori Kondo ◽  
Kazunari Tanabe ◽  
Shuji Sakai

Sign in / Sign up

Export Citation Format

Share Document